Spanish Red Biotech Pipeline

Oryzon

Iadademstat (ORY-1001) - Selective LSD1 inhibitor

Type: Biodrugs/ Drugs
Therapeutic area:
Indication: AML - R/R-Flt3 mut+ Clinical Trial "FRIDA" (combo w gilteritinib) IND approved FPI 1H22
Phase: 1Phase I, 2Regulatory Preclinical, 1Non Regulatory Preclinical